Loading clinical trials...
Loading clinical trials...
A Double-Blind, Randomized, Cross-Over Study of The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo, in Patients With Allergic Rhinitis and Allergic Conjunctivitis in an Environmental Exposure Chamber (EEC) Model
Conditions
Interventions
Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops
Placebo
Locations
1
Canada
Cetero Research
Mississauga, Ontario, Canada
Start Date
September 1, 2009
Primary Completion Date
March 1, 2010
Completion Date
March 1, 2010
Last Updated
January 30, 2026
NCT07419230
NCT06732414
NCT05494346
NCT07110311
NCT04815668
NCT06846385
Lead Sponsor
Bitop AG
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions